Panasonic unveils CardioHealth Station in Europe
23 Nov 2010
Panasonic has unveiled in Europe its new device designed to
assist medical professionals in making a quick assessment of
cardiovascular health, the CardioHealth Station.
The device is expected to be available in Europe by spring 2011
after obtaining all necessary regulatory approvals.
Recently published studies (ARIC & MESA)have shown that valuable
information is revealed in the assessment of vascular health, and
the risks of a cardiovascular event associated with those
assessments  .
The ARIC study , a recent multi-institution study, reveals
that certain patients can be reclassified by looking at the carotid-intima
media thickness and the presence of plaque in the said patient. As a
result, Panasonic developed CardioHealth Station, a much needed
device that will help the doctor, and in some cases the technician,
quickly detect thickened carotid arteries.
The carotid artery is the branch that goes from the heart up the
neck, and provides blood to the front of the face and the brain.
What once used to be difficult and impractical to do on a mass basis
is now made possible by the innovative automation technology loaded
as standard in the CardioHealth Station.
Professor Raimund Erbel, Department of Cardiology, West-German
Heart Center Essen, welcomes this novel development: "The ultrasound
of carotid arteries is critical because physicians, and in
particular cardiologists, agree that this leads to a more accurate
assessment of patient risk than looking at risk factors alone."
The CardioHealth Station has a built-in portable ultrasound
system optimized to perform a non-invasive examination of the
peripheral vessels. It provides an automated measurement of the
intima-media thickness (IMT) of peripheral arteries such as the
common carotids and allows the user to search for arterial plaques
using real-time B-mode imaging.
The touchscreen keyboard allows the user to input various
parameters relating to traditional cardiovascular risk factors. A
built in calculator provides risk scores commonly used in a variety
of geographical locations (Framingham Risk Score, PROCAM Health
Check Score, Reynolds Risk Score, Risk score based on the SCORE
Project). This information is supplemented with an IMT measurement
of the artery to generate a comprehensive report to aid the
physician in assessing cardiovascular risk.
Chairman and CEO of Panasonic Europe Ltd. Laurent Abadie, stated,
"We at Panasonic see the CardioHealth Station as a step forward in
personalized preventive medicine. Not only will it enhance patient
outcomes, but it has the potential to reduce healthcare costs in
Europe through early detection and quicker diagnosis."
In May, the president of Panasonic Corporation, Fumio Ohtsubo
stated Panasonic's worldwide intention to reinforce the healthcare
business and he announced the plan to change its subsidiary's name
from Panasonic Shikoku Electronics Co.,Ltd to Panasonic Healthcare
Co., Ltd on October 1, 2010. On October 25, Panasonic Corporation of
North America announced the formation of CardioNexus Corporation,
which became the launching platform for CardioHealth Station in
North America on November 14th. Panasonic is currently applying for
FDA and EMA approval of the CardioHealth Station, and expects sales
to begin as soon as approval is received from the appropriate
"Helping the world reduce global healthcare costs is in
everybody's interest," said Osamu Takahashi, the Director of Global
Strategy at Panasonic Healthcare Co., Ltd. "Panasonic believes the
CardioHealth Station, a first in a series of products — will help
achieve the corporate goal of improving society through the early
detection of disease."
1. Atherosclerosis Risk in Communities (ARIC) and the ongoing
Multiethnic Study of Atherosclerosis (MESA). Both studies are
sponsored by the National Heart Lung and Blood Institute. More
information about the ARIC study can be found at
more information about the MESA study can be found at
2. ARIC study can be found at